A simple core dataset for triglyceride-induced acute pancreatitis

Current diagnostic and monitoring practices for triglyceride-induced acute pancreatitis (TG-IAP) vary widely across treatment centers. While prior research has shown that standardized datasets improve patient outcomes in other acute conditions, no consensus exists for TG-IAP. This gap motivated the development of a core dataset to ensure consistent data collection. Existing literature highlights variability in diagnostic criteria and monitoring parameters. No prior work had resolved how to standardize these elements for TG-IAP. The absence of a unified dataset hinders comparative studies and personalized treatment approaches. This paper addresses the need for a minimum dataset that can be universally applied. Prior efforts focused on general acute pancreatitis rather than TG-IAP specifically. The authors aim to bridge this gap by synthesizing expert opinion and published evidence.

The study aimed to develop a core clinical dataset for triglyceride-induced acute pancreatitis (TG-IAP) by integrating expert consensus and published evidence. This dataset would serve as a standardized framework for data collection across treatment centers. The goal is to improve diagnostic accuracy and monitoring consistency for TG-IAP patients. The initiative responds to the lack of uniformity in current diagnostic practices. The authors sought to address variability in how TG-IAP is diagnosed and managed. By creating a minimum dataset, the study aims to facilitate better patient management and outcomes. The dataset is intended to inform personalized treatment plans and track disease progression. This approach may help reduce delays in diagnosis and improve overall care for TG-IAP patients.

The Jandhyala Method was employed to gather expert opinions from ten specialists in TG-IAP treatment across the US and EU. A systematic literature review was conducted using the PRISMA protocol, screening 6718 studies and extracting data from 123 relevant ones. A total of 243 items were identified from the literature review and combined with survey data from an Awareness Round. These items formed the basis of a Consensus Round survey, where 80% of the items met the consensus threshold. The SMART interview phase was used to refine the dataset further, balancing stakeholder input to eliminate bias. Experts evaluated 195 items, reducing them to 109 that formed the diagnostic and monitoring procedures. The final dataset was condensed to 87 core items through consensus and validation. This approach ensured that the dataset reflects both published evidence and expert clinical experience.

The final core dataset for TG-IAP comprises 87 items, selected from an initial pool of 243 through expert consensus and literature review. These items were validated by ten specialists in TG-IAP treatment across the US and EU. The dataset includes diagnostic and monitoring parameters essential for consistent patient management. The process involved extracting data from 123 studies identified from 6718 screened using PRISMA. A total of 195 items met the consensus threshold for inclusion in the dataset. These items were further refined to 109 that all experts agreed upon after balancing stakeholder input. The dataset was condensed to 87 items to ensure practicality and relevance. This dataset may improve the speed and accuracy of TG-IAP diagnosis and monitoring. The items cover key aspects of disease progression and patient outcomes.

The authors propose that the TG-IAP core dataset will enhance patient management by standardizing diagnostic and monitoring procedures. This dataset may improve diagnostic accuracy and reduce variability in care across treatment centers. The 87 items in the dataset reflect both published evidence and expert consensus. The dataset is intended to inform personalized treatment plans and track disease progression. The authors suggest that this approach may lead to better patient outcomes and more efficient care. The dataset was validated through expert input and stakeholder consensus. The authors emphasize the importance of adopting this dataset in clinical practice. This initiative may help standardize TG-IAP management and improve overall care quality.